Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860698 · ClinicalTrials.gov registry record
The Impact of Chronic E-Cigarette Usage on Microvascular Health
A clinical trial of E-Cig Use, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- 44
- Enrollment target
- 1
- Study location
NCT06860698: Recruiting study of E-Cig Use, sponsored by Virginia Commonwealth University.
NCT06860698 is a study of E-Cig Use that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 44 participants, below the 147-participant average among 9 other E-Cig Use trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06860698, a study of E-Cig Use, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is focused on investigating the mechanisms involved in microvascular health in subjects that use e-cigarettes frequently. To explore microvascular health, different techniques and compounds. For one of the tests, iontophoresis, the drug's use will be stored and handled as described by the approved IND and non-IDS plan.
Primary Outcome
Endothelial-dependent dilation will be assessed using laser doppler speckle contrast in both groups through the intervention
Conditions Studied
Interventions
- OTHER E-cig use
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2026-02-28 |
What NCT06860698 shows while recruiting
NCT06860698 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 147-participant average among 9 other E-Cig Use trials with a reported enrollment target (70% lower).
The record links to 1 condition, with E-Cig Use appearing as the primary indexed condition, and to 1 intervention - of which E-cig use is the first listed.
NCT06860698 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06860698 about?
NCT06860698 is a clinical study titled "The Impact of Chronic E-Cigarette Usage on Microvascular Health". The study is focused on investigating the mechanisms involved in microvascular health in subjects that use e-cigarettes frequently. To explore microvascular health, different techniques and compounds. For one of the tests, iontophoresis, the drug's use will be stored and handled as described by the ...
What is the current status of trial NCT06860698?
This trial is currently recruiting. The enrollment target is 44 participants. The study started on 2023-07-14. Estimated completion is 2026-02-28.
What conditions does trial NCT06860698 study?
This clinical trial studies the following conditions: E-Cig Use.
What interventions are being tested in trial NCT06860698?
The interventions under investigation include: E-cig use (OTHER).
Who is sponsoring clinical trial NCT06860698?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860698 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for E-Cig Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06860698's enrollment target sits among peer trials
44 8th of 9 higher than 2 of 9 other E-Cig Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other E-Cig Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BREATHE Free: a Pilot Feasibility Trial
RECRUITING · NA
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
RECRUITING
-
Hyperpolarized Xenon-129 MR Imaging of the Lung
RECRUITING · Phase 1
-
The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers
RECRUITING · NA
-
Respiratory Effects of E-Cigarettes in Obese Youth
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI